Conatus Pharma's IDN-7314 shows encouraging action in preclinical studies; shares up 4% premarket [Seeking Alpha]
CONATUS PHARMACEUTICALS INC (CNAT)
Last conatus pharmaceuticals inc earnings: 11/5 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.conatuspharma.com/investor-relations
Company Research
Source: Seeking Alpha
Conatus Pharma's IDN-7314 shows encouraging action in preclinical studies; shares up 4% premarketConatus Pharmaceuticals (NASDAQ:CNAT) is up4% premarket on light volume in response to itsannouncement that results from preclinical studies of liver disease candidate IDN-7314 have just beenpublished inToxicological Sciences.The data suggest that a pan-caspase inhibitor could potentially reduce excessive clotting in patients with severe liver disease such as primary sclerosing cholangitis (PSC), an Orphan Drug indication.IDN-7314 is an orally available pan-caspase protease inhibitor designed to reduce the activity of enzymes that play a key role in inflammation and cell death (apoptosis). The FDA designated the candidate an Orphan Drug for PSC in June 2017 followed by the EMA four months later.See all stocks on the move »Now read:3 Things In Biotech, April 9: Clovis Hunts Anew, Conatus Falters, Newlink Soul Searches »
Show less
Read more
Impact Snapshot
Event Time:
CNAT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CNAT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CNAT alerts
High impacting CONATUS PHARMACEUTICALS INC news events
Weekly update
A roundup of the hottest topics